Cognitive Intervention via Mobile App for Eating Disorders: An Exploratory Case Series in Remission-Phase Patients
Abstract
Relapse following treatment is a frequent occurrence in individuals with eating disorders (EDs), highlighting the importance of developing preventive interventions. The GG Eating Disorders (GGED) module is designed to address dysfunctional beliefs that contribute to the development and maintenance of these disorders through its use within a mobile application. The aim of this exploratory case series study is to analyze the efficacy of GGED in reducing ED-related dysfunctional beliefs and eating symptomatology and increasing body satisfaction and self-esteem among three patients with EDs in remission. Following the use of GGED, patients showed a decrease in most dysfunctional beliefs and ED symptoms, accompanied by an increase in body satisfaction and self-esteem. However, these changes did not reach clinical significance in all patients. The GGED module has the potential to serve as a very useful tool in maintaining cognitive changes following cognitive behavioral therapy and thus preventing relapse.Clinical Trial Registration: This study was registered with ClinicalTrials.gov (Identifier NCT06842862).
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.